Details of the Drug

General Information of Drug (ID: DMM29N9)

Drug Name
INV103
Indication
Disease Entry ICD 11 Status REF
Systemic lupus erythematosus 4A40.0 Phase 2 [1]
Cross-matching ID
TTD ID
D0P8UN

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)